TABLE 1.
Baseline (week 0) characteristics presented as mean ±SD or number of patients (%)
| RYGB n = 41 | Diet n = 41 | Control n = 18 | |
|---|---|---|---|
| Sex, n (male/female) | 14/27 | 14/27 | 3/15 |
| Age (years) | 46 ± 9 | 49 ± 10 | 42 ± 15 |
| Ethnicity, n (White/other) | 41/0 | 40/1 | 17/1 |
| Body weight (kg) | 132 ± 24 | 124 ± 23 | 71 ± 11 |
| BMI (kg/m2) | 44.5 ± 6.2 | 42.0 ± 5.4 | 25.0 ± 3.5 |
| Albumin (g/L) | 40 ± 2 | 40 ± 2 | 40 ± 2 |
| Creatinine (µmol/L) | 58 ± 11 | 59 ± 14 | 60 ± 12 |
| AST (U/L) | 29 ± 11 | 28 ± 15 | 25 ± 11 |
| ALT (U/L) | 34 ± 17 | 32 ± 18 | 22 ± 15 |
| hs‐CRP (mg/L) | 8.1 ± 6.3 | 8.2 ± 9.6 | 2.5 ± 3.8 |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; hs‐CRP, high sensitivity C‐reactive protein; RYGB, Roux‐en‐Y gastric bypass.